You searched for "Wales"

3018 results found

Andy Hill (NuVision Biotherapies) discusses recent AOP update to clinical guidelines

There are currently 600,000 people on the NHS waiting list for ophthalmology treatment, and over 5 million people in the UK currently live with dry eye disease. Here Andy Hill, CEO at NuVision Biotherapies Ltd, discusses a recent update to clinical guidelines and what this means for optometrists, patients, and taxpayers.

Cornea, 2-Volume Set: Fundamentals, Diagnosis, Management and Surgery of the Cornea and Conjunctiva (4th Edition)

Originally published in 1997 as a comprehensive set of three volumes on cornea and external eye disease, this two volume edition, published at the end of 2016, offers “a complete multimedia resource, in print, online, eBook and video format”. There...

Papilloedema: an update

Some readers may have seen a recent report in the national newspapers of the case of a teenage girl with persistent severe headache associated with a fatal brain tumour having been undiagnosed despite many consultations with her medical advisers. It...

The College of Optometrists’ prestigious Research Excellence Awards 2025 are open for public nominations

The College of Optometrists has opened submissions for its annual Research Excellence Awards, which recognise and celebrate inspirational individuals who are making a significant contribution to the evidence base that underpins good practice, now and in the future. The College...

ST1 Ophthalmology Interview Course Free Introduction Webinar

Free Introduction webinar to ST1 Ophthalmology Interview Course Course dates are: Saturday 20th January 2024 (virtual)Saturday 10th February 2024 (virtual)Saturday 24th February 2024 (in-person)Saturday 2nd March 2024 (in-person) This course is run by current trainees successful in the 2023 application...

ST1 Ophthalmology Interview Course 10 Feb 24 (Virtual)

This course is run by current trainees successful in the 2023 application cycle, with multiple members scoring 100% on the interview and ranking in the top 10 nationally. The course is designed to maximise your chances of success. Interview Course•...

ST1 Ophthalmology Interview Course 24 Feb 24 (in-person)

This course is run by current trainees successful in the 2023 application cycle, with multiple members scoring 100% on the interview and ranking in the top 10 nationally. The course is designed to maximise your chances of success. Interview Course•...

ST1 Ophthalmology Interview Course 2 March 24 (in-person)

This course is run by current trainees successful in the 2023 application cycle, with multiple members scoring 100% on the interview and ranking in the top 10 nationally. The course is designed to maximise your chances of success. Interview Course•...

Non-arteritic anterior ischaemic optic neuropathy (NA-AION): a review

Ischaemic optic neuropathy (ION) is the commonest adult optic neuropathy encountered today in our ageing population, is a common cause of irreversible visual loss and is usually associated with underlying vascular disease. The condition is classified as follows: (a) Anterior...

The eye without tears

The Art is long and Life is short. So goes the dispiriting tag in Latin and flung from day one and at regular intervals thereafter at idle medical students who, inevitably brainwashed, come by graduation to believe that the only...

Aflibercept, bevacizumab or ranibizumab for DMO

This is a two-year randomised clinical trial of 660 patients with visual acuity impairment from diabetic macular oedema (DMO) who were randomised to monthly injections of 2.0mg aflibercept, 1.25 mg bevacizumab or 0.3mg ranibizumab. Focal or grid laser was performed...

Sight Scotland report calls for improved accessibility in Scottish venues

Sight Scotland and Sight Scotland Veterans have today launched a new accessible venues report, "Enhancing Accessibility: Venues and Visual Impairment," ahead of Scotland's summer festivals and Fringe in the capital. The report reveals significant gaps in accessibility and calls for comprehensive changes to ensure equal access for all.